ArticleAmerican journal of hematology2021

Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia.

Nitin Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.